Genetic testing: Leading the way in preventive care for Southeast Asia

In a region plagued by diseases such as heart disease, stroke, cancer, diabetes and neonatal deaths, NalaGenetics is taking a stand. As a prominent provider of genetic testing solutions, this pioneering company is on a mission to combat these ailments and improve patient outcomes in Southeast Asia. Its recent appearance at the UBS Healthcare Summit 2023 showcased their innovative approach and solidified their commitment to promoting preventive care.

Preventive care is a crucial aspect of healthcare that deserves more attention. With skyrocketing healthcare costs and the burden of invasive treatments, it is imperative that we shift our focus to proactive measures. NalaGenetics recognizes this urgency and aims to empower individuals in Southeast Asia to identify their risk for these diseases and take necessary steps to prevent them.

Southeast Asia stands out with its alarmingly high prevalence of deadly diseases. According to the World Health Organization (WHO), 33% of deaths in the region are caused by heart diseases. Aside from heart diseases and stroke, colorectal cancer, diabetes, and neonatal deaths are the other leading causes of death in Southeast Asia. This reality underscores the importance of NalaGenetics’ genetic testing solutions. By identifying individuals’ genetic risk factors for these diseases, healthcare providers can tailor preventive care plans, making them more targeted and effective. This, in turn, reduces the strain on the healthcare system and ultimately improves patient outcomes. Genetic tests are powerful because they can significantly impact our health in numerous ways: From helping us to detect genetic disorders, personalizing medicine to giving us insights into our risk of developing certain diseases later in life.

Levana Sani, Co-Founder of NalaGenetics, shared her personal experience during the UBS Healthcare Summit 2023. She highlighted the challenges faced and the ways in which genetic testing can be integrated to enhance patient outcomes and well-being in Southeast Asia. Sani’s firsthand account of how her grandfather went into seizures due to the wrong medication prescription was not only a devastating story, it also serves as a cautionary tale for many of us. It is through this motivation that fuels NalaGenetics’ commitment to supporting preventive care and tackling the diseases plaguing the region.

NalaGenetics’ mission goes beyond individual health. By embracing the latest advances in genetic research, this Southeast Asian leader strives to alleviate the burden on the healthcare system. With millions of lives at stake, their work has never been more important. By promoting preventive care and encouraging individuals to take charge of their health, NalaGenetics is spearheading a much-needed paradigm shift in healthcare.

As we move forward, it is crucial that we continue to support companies like NalaGenetics in their efforts to improve patient outcomes and promote preventive care. By harnessing the power of genetic testing, we can revolutionize the way we approach healthcare in Southeast Asia. Let us rally behind NalaGenetics and embrace a future where deadly, preventable diseases are thwarted before they can claim another life.

At the summit, NalaGenetics showcased its revolutionary genetic testing solutions, giving attendees a glimpse into the potential of this groundbreaking technology. Visitors had the opportunity to learn how genetic testing can identify health risks and provide practical solutions for prevention. Moreover, attendees were able to take home testing kits, allowing them to explore their genetic profiles from the comfort of their own homes.

This article is a summary of two articles. Read the original articles at Tempo and Antaranews.com.